A logo

Agilent Technologies, Inc. Stock Price

NYSE:A Community·US$43.4b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 42 Fair Values set on narratives written by author

A Share Price Performance

US$153.50
13.92 (9.97%)
US$167.57
Fair Value
US$153.50
13.92 (9.97%)
0.8% overvalued intrinsic discount
US$152.33
Fair Value
Price US$153.50
AnalystConsensusTarget US$152.33

A Community Narratives

AnalystConsensusTarget·
Fair Value US$167.57 8.4% undervalued intrinsic discount

A: Global Healthcare Trends And New Diagnostic Solutions Will Shape Future Performance

0users have liked this narrative
0users have commented on this narrative
25users have followed this narrative

Trending Discussion

Updated Narratives

A logo

A: New Diagnostic Solutions And Leadership Will Shape Measured Prospects Ahead

Fair Value: US$167.57 8.4% undervalued intrinsic discount
25 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet with acceptable track record.

0 Risks
3 Rewards

Agilent Technologies, Inc. Key Details

US$6.9b

Revenue

US$3.3b

Cost of Revenue

US$3.6b

Gross Profit

US$2.3b

Other Expenses

US$1.3b

Earnings

Last Reported Earnings
Oct 31, 2025
Next Reporting Earnings
n/a
4.60
52.43%
18.75%
49.8%
View Full Analysis

About A

Founded
1999
Employees
18000
CEO
Padraig McDonnell
WebsiteView website
www.agilent.com

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. This segment also offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. The Diagnostics and Genomics segment provides genomics, contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses; and cell analysis plate based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, and related consumables. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Recent A News & Updates

Agilent Technologies, Inc. (NYSE:A) Analysts Are Pretty Bullish On The Stock After Recent Results

Nov 27
Agilent Technologies, Inc. (NYSE:A) Analysts Are Pretty Bullish On The Stock After Recent Results

Recent updates

No updates